BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiménez-Pérez M, González-Grande R, Rando-Muñoz FJ. Management of recurrent hepatitis C virus after liver transplantation. World J Gastroenterol 2014; 20(44): 16409-16417 [PMID: 25469009 DOI: 10.3748/wjg.v20.i44.16409]
URL: https://www.wjgnet.com/1007-9327/full/v20/i44/16409.htm
Number Citing Articles
1
Akshay D. Baheti, Rupan Sanyal, Matthew T. Heller, Puneet Bhargava. Surgical Techniques and Imaging Complications of Liver TransplantRadiologic Clinics of North America 2016; 54(2): 199 doi: 10.1016/j.rcl.2015.09.004
2
B.-H. Jung, J.-I. Park, S.-G. Lee. Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case ReportTransplantation Proceedings 2018; 50(9): 2877 doi: 10.1016/j.transproceed.2018.03.057
3
Prajakta S. Badri, Apurvasena Parikh, Eoin P. Coakley, Bifeng Ding, Walid M. Awni, Sandeep Dutta, Rajeev M. Menon. Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C InfectionTherapeutic Drug Monitoring 2016; 38(5): 640 doi: 10.1097/FTD.0000000000000315
4
T.C. Wirth, M.P. Manns. The impact of the revolution in hepatitis C treatment on hepatocellular carcinomaAnnals of Oncology 2016; 27(8): 1467 doi: 10.1093/annonc/mdw219
5
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantationPortal Hypertension & Cirrhosis 2024; 3(1): 22 doi: 10.1002/poh2.70
6
M. Berenguer, K. Agarwal, P. Burra, M. Manns, D. Samuel. The road map toward an hepatitis C virus-free transplant populationAmerican Journal of Transplantation 2018; 18(10): 2409 doi: 10.1111/ajt.14976
7
Anne M. Larson, George B. McDonald. Transplant Infections2016; : 653 doi: 10.1007/978-3-319-28797-3_36
8
Blanca C. Lizaola-Mayo, Hugo E. Vargas, David M. Chascsa. Hepatitis C-Positive Organs for Liver and Kidney Transplantation—Emerging Data and Current Management StrategiesCurrent Hepatology Reports 2019; 18(2): 228 doi: 10.1007/s11901-019-00465-1
9
Farina M Hanif, Zain Majid, Nasir Hassan Luck, Abbas Ali Tasneem, Syed Muddasir Laeeq, Muhammed Mubarak. Revolution in the diagnosis and management of hepatitis C virus infection in current eraWorld Journal of Hepatology 2022; 14(4): 647-669 doi: 10.4254/wjh.v14.i4.647
10
Giuliano Ramadori, Patrizia Bosio, Federico Moriconi, Ihtzaz A. Malik. Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapyBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4175-2
11
Rocío González-Grande, Miguel Jiménez-Pérez, Carolina González Arjona, José Mostazo Torres. New approaches in the treatment of hepatitis CWorld Journal of Gastroenterology 2016; 22(4): 1421-1432 doi: 10.3748/wjg.v22.i4.1421